Company intelligence / Profile preview

Alpenglow Biosciences

Seattle, Washington, United Statesalpenglowbiosciences.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Alpenglow Biosciences has developed a patented AI-powered open-top light-sheet microscopy platform that enables non-destructive digitization of entire tissues in three dimensions. Their Aurora™ system integrates advanced imaging hardware with automated data management and deep-learning-based image analysis to provide unprecedented insight into tissue architecture. The company’s assays—such as the “3D Derm Score” for dermatology and “3D I/O Pro Assay” for immuno-oncology—are currently available for research use only. Five of the top ten pharmaceutical companies are customers or partners. The company has secured over $24M from ARPA-H/NIH grants to accelerate its transition from biopharma research tool to high-impact clinical assay provider.

Therapeutic areas
OncologyImmunologyOtherDermatologyNeurology
Modalities
Device (AI-enabled 3D imaging platform)Non-pharmacological therapy (enabling technology for drug development and diagnostics)Software (AI-driven analysis and spatial profiling tools)
Industry
Pathology
02

Partnerships

ZEISS Research Microscopy Solutions – co-development of inverted light-sheet microscope/bioinformatics pipeline tailored to clinical pathology applicationsMolecular Instruments – partnership on high-resolution RNA imaging using HCR Gold reagents with Alpenglow’s HOTLS systemPharmaceutical partners include five of the top ten pharma companies globally; named customers include GlaxoSmithKline (“GSK”), Mayo Clinic, Incyte Therapeutics.

Beyond the preview

Go deeper on Alpenglow Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpenglow Biosciences.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call